Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Request For Help On Hemp Regulation Gets Lower Profile In House Appropriators' Report

Jul 11 2024

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US FDA Doubts Hemp ‘Derivatives Created From Scratch’ Belong In Lawful Use Pathway

Feb 06 2023

US FDA ‘Punt’ On Hemp Rulemaking Frustrates, Confuses Supplement Industry

Jan 27 2023

Biden Administration's $7.13Bn FDA Budget Request For FY2025 Includes $3.3Bn In User Fees

Mar 12 2024

In Proposed Appropriation, Congress Tells FDA To Repurpose $7M For Cosmetic Regulation

Mar 05 2024

Industry Groups Put It In Writing: House Hearing Needed On FDA Hemp 'Regulation, Or Lack Thereof'

Jan 26 2024

Resolving US Hemp Dilemma Takes Detour As House Starts Farm Bill Re-Authorization Journey

May 28 2024

US FDA May See Second Straight Year of Non-User Fee Funding Cuts From Congress

Jun 19 2024

CBD Market Provides ‘Enormous Incentive’ For FDA's Regulatory Answer But Decision Remains TBD

Dec 10 2020

FDA Road To Decision On Expanding CBD Uses Starts With Weighing Impact On Existing And Future Use As Drug

Jun 03 2019

Additional Topics

International United States Cannabidiol CBD Legislation Politics Commercial Compliance Consumer Dietary Supplements Enforcement FDA Ingredients Manufacturing Policy Regulation Retail

More from Cannabis/CBD

More from Ingredients & Safety

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window